Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Symbol: KNSA (NASDAQ)
38.10
▼ (-0.02%) -0.006
Company Description:
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Key Stats
- Today's Open: $38.11
- Today's High: $38.49
- Today's Low: $37
- Today's Volume: 460.46K
- Yesterday Close: $38.11
- Yesterday High: $39.43
- Yesterday Low: $38.06
- Yesterday Volume: 394.64K
- Last Min Volume: 0
- Last Min High: $38.104
- Last Min Low: $37.891
- Last Min VWAP: $0
Company Profile
- Name: Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
- Website: https://www.kiniksa.com
- Listed Date: 2018-05-24
- Location: LONDON, X0
- Market Status: Active
- CIK Number: 0001730430
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.81B
- Round Lot: 100
- Outstanding Shares: 74.11M
- Asset Type: CS
RECENT FILINGS FOR KNSA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-08 | 4 | View |
| 2025-10-01 | 4 | View |
| 2025-09-29 | 144 | View |
| 2025-09-17 | 4 | View |
| 2025-09-15 | 144 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-05 | 144 | View |
| 2025-09-04 | 144 | View |
| 2025-09-04 | 144 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 144 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 144 | View |
| 2025-09-03 | 8-K | View |
| 2025-08-20 | 4 | View |
Latest News on KNSA